Mycophenolate Mofetil | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Mycophenolate Mofetil
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Mycophenolate Mofetil

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

50 API Suppliers, 29 USDMF, 18 CEP/COS, 2 JDMF, 8 EU WC, 9 KDMF, 17 NDC API, 27 Listed Suppliers, $ API Reference Price

50 API Suppliers
29 USDMF
18 CEP/COS
2 JDMF
8 EU WC
9 KDMF
17 NDC API
27 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

19 Drugs in Development

19 Drugs in Development

FINISHED DOSAGE FORMULATIONS

162 FDF Dossiers, 45 FDA Orange Book, 60 Europe, 16 Canada, 13 South Africa, 28 Listed Dossiers

162 FDF Dossiers
45 FDA Orange Book
60 Europe
16 Canada
13 South Africa
28 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 250MG, TABLET;ORAL - 500MG, FOR SUSPENSION;ORAL - 200MG/ML

CAPSULE;ORAL - 250MG
TABLET;ORAL - 500MG
FOR SUSPENSION;ORAL - 200MG/ML

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 6 SPI Pharma, 2 Seqens, 17 DKSH, 1 Pharm-RX Chemical, 5 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 26 BASF, 2 Clariant, 10 Corel Pharma Chem, 3 DFE Pharma, 2 Finar, 11 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 17 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 9 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 25 Roquette, 14 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

61 Fillers, Diluents & Binders, 56 Coating Systems & Additives, 33 Controlled & Modified Release, 30 Thickeners and Stabilizers, 26 Solubilizers, 24 Film Formers & Plasticizers, 21 Topical, 20 Direct Compression, 19 Disintegrants & Superdisintegrants, 19 Granulation, 17 Parenteral, 17 Lubricants & Glidants, 14 Taste Masking, 13 Co-Processed Excipients, 9 Empty Capsules, 9 Emulsifying Agents, 9 Chewable & Orodispersible Aids, 8 API Stability Enhancers, 7 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 1 Soft Gelatin

61 Fillers, Diluents & Binders
56 Coating Systems & Additives
33 Controlled & Modified Release
30 Thickeners and Stabilizers
26 Solubilizers
24 Film Formers & Plasticizers
21 Topical
20 Direct Compression
19 Disintegrants & Superdisintegrants
19 Granulation
17 Parenteral
17 Lubricants & Glidants
14 Taste Masking
13 Co-Processed Excipients
9 Empty Capsules
9 Emulsifying Agents
9 Chewable & Orodispersible Aids
8 API Stability Enhancers
7 Rheology Modifiers
5 Coloring Agents
4 Vegetarian Capsules
4 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

21 NEWS #PharmaBuzz

21 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 55 Finished Drug Prices, 10 Annual Reports

1 US Medicaid Prescriptions
55 Finished Drug Prices
10 Annual Reports

MARKET PLACE

13 APIs, 8 FDF Dossiers

13 APIs
8 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 US Patents, 6 Health Canada Patents

3 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 3 USP, 4 Others

2 EDQM
3 USP
4 Others

$ API Ref.Price (USD/KG) : 177 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 2Gowling Lafleur Henderson LLP

02 4Hoffmann-La Roche Limited

filter Patent Reset all filters

6 All

01 41333285

02 12171836

03 12172506

filter Product Reset all filters

6 All

01 6Mycophenolate Mofetil

filter Dosage Reset all filters

6 All

01 1Capsule

02 2Intravenous

03 2Powder for Suspension

04 1Tablet

filter Exp Date Reset all filters

6 All

01 42011-11-29

02 12014-09-12

03 12014-09-27

Product Main Page

01

Hoffmann-La Roche Limited

Mycophenolate Mofetil

BioAsia

Not Confirmed

Hoffmann-La Roche Limited

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-11-29

Date Granted : 1994-11-29

Mycophenolate Mofetil

Brand Name : CELLCEPT

Patent Number : 1333285

Filing Date : 1987-12-15

Strength per Unit : 200mg / ml

Dosage Form : Powder for Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-11-29

Date Granted : 1994-11-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Hoffmann-La Roche Limited

Mycophenolate Mofetil

BioAsia

Not Confirmed

Hoffmann-La Roche Limited

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-11-29

Date Granted : 1994-11-29

Mycophenolate Mofetil

Brand Name : CELLCEPT

Patent Number : 1333285

Filing Date : 1987-12-15

Strength per Unit : 250mg

Dosage Form : Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-11-29

Date Granted : 1994-11-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Hoffmann-La Roche Limited

Mycophenolate Mofetil

BioAsia

Not Confirmed

Hoffmann-La Roche Limited

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-11-29

Date Granted : 1994-11-29

Mycophenolate Mofetil

Brand Name : CELLCEPT

Patent Number : 1333285

Filing Date : 1987-12-15

Strength per Unit : 500mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-11-29

Date Granted : 1994-11-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Hoffmann-La Roche Limited

Mycophenolate Mofetil

BioAsia

Not Confirmed

Hoffmann-La Roche Limited

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-11-29

Date Granted : 1994-11-29

Mycophenolate Mofetil

Brand Name : CELLCEPT

Patent Number : 1333285

Filing Date : 1987-12-15

Strength per Unit : 500mg/vial

Dosage Form : Intravenous

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2011-11-29

Date Granted : 1994-11-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Gowling Lafleur Henderson LLP

Mycophenolate Mofetil

BioAsia

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-09-12

Date Granted : 2006-11-14

Mycophenolate Mofetil

Brand Name : CELLCEPT

Patent Number : 2171836

Filing Date : 1994-09-12

Strength per Unit : 500mg/vial

Dosage Form : Intravenous

Human Or VET : Human

Route of Administration : Intravenous

Patent Expiration Date : 2014-09-12

Date Granted : 2006-11-14

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Gowling Lafleur Henderson LLP

Mycophenolate Mofetil

BioAsia

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-09-27

Date Granted : 2007-07-17

Mycophenolate Mofetil

Brand Name : CELLCEPT

Patent Number : 2172506

Filing Date : 1994-09-27

Strength per Unit : 200mg / ml

Dosage Form : Powder for Suspension

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-09-27

Date Granted : 2007-07-17

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!